| |
Guru Picks
Page 5 of 6 from Top Gurus' Best Bets
04.10.02, 12:00 PM ET
Josh Wolfe
Editor
Forbes/Wolfe Nanotech Report
IBM
(nyse:
IBM -
news
-
people
)
IBM's recent dip is a buying opportunity for investors interested in what many scientists and top government officials are hailing as the next technological revolution: nanotechnology. Since 1989, IBM has been the hands-down leader in this new science, obtaining over 700 nanotech patents. In the next decade IBM will begin to reap the rewards of these patents through licensing and joint ventures. IBM's patent portfolio earned more than $1.5 billion in royalties in 2001.* Its Nano patents should eventually add billions to this. The company is also set to profit from its own nanotech products. Take "Millipede," a nanotech approach to information storage that does away with the ubiquitous spinning disk. The Millipede will eventually store up to an incredible 1 terabit of data per square inch, in comparison to the 35 gigabits of today's magnetic-disk drives. That's a nearly 40-fold improvement in data density. Millipede is not a pie-in-the-sky dream. It should be out within two years. IBM will be a big factor in nanotechnology. Its stock at $87.91 is a good long-term holding.
*A previous version of this story had the incorrect royalties amount.
');
//-->
News Headlines | More From Forbes.com | Special Reports
Subscriptions >
|
|
|
Brought to you by the sponsors below
|
|
|
|
|
|
|
|
|
|
|